Novartis AG

Open: 103.42 Close: 104.71 Change: 1.29

An AI to read internet: The best strategy to evaluate Novartis AG.

Are looking for the most relevant information about Novartis AG? Investor spend a lot of time searching for information to make investment decisions in Novartis AG. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, AG, Sandoz, spin, share, price, average, and the most common words in the summary are: novartis, stock, news, market, ag, drug, company, . One of the sentences in the summary was: Novartis AG raised its profit outlook and announced plans to buy …

Concept Map

Semantic Network

Stock Summary

Novartis AG researches, develops, manufactures, markets, markets healthcare products. The company operates through two segments: Innovative Medicines and Sandoz. Novarti has a license and collaboration agreement with Alnylam Pharmaceuticals.

Today's Summary

Novartis AG raised its profit outlook and announced plans to buy back as much as $15 billion in shares. FDA approved tisagenlecleucel for relapsed or refractory follicular lymphoma.

Today's News

Novartis AG To Spin-Off Sandoz business in 4Q23. Shareholders will be invited to vote on the proposed spin off and a related reduction. Novartis AG raised its profit outlook and announced plans to buy back as much as $15 billion in shares as it prepares to spin off its Sandoz generics unit. FDA approved tisagenlecleucel for relapsed or refractory follicular lymphoma. Novartis AG has 2.12 billion shares outstanding. The beta is 0.47, so the price volatility has been lower than the market average. The average one-year price target is 109.33. Novartis AG (NVS) Stock Price, News, Quotes-Moomoo Download Mobile Desktop Download now.

Stock Profile

"Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland."

Keywords

The game is changing. There is a new strategy to evaluate Novartis AG fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, AG, Sandoz, spin, share, price, average, and the most common words in the summary are: novartis, stock, news, market, ag, drug, company, . One of the sentences in the summary was: Novartis AG raised its profit outlook and announced plans to buy back as much as $15 billion in shares. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #novartis #stock #news #market #ag #drug #company.